Skip to main content
Clinical Trials/NL-OMON43560
NL-OMON43560
Completed
Not Applicable

The role of catecholaminergic neurotransmission in attention and cognition - Catecholamines, attention and cognition

Medisch Universitair Ziekenhuis Maastricht0 sites20 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
aandacht en leer problemen
Sponsor
Medisch Universitair Ziekenhuis Maastricht
Enrollment
20
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional

Investigators

Sponsor
Medisch Universitair Ziekenhuis Maastricht

Eligibility Criteria

Inclusion Criteria

  • In order to be eligible to participate in this study, a subject must meet all of the following criteria:
  • \* No use of any psychopharmacological treatment at in the past or at time of inclusion.
  • \* No presence of a physical/medical condition that may interfere with the study
  • \* No contradiction for MRI
  • \* Age between 18 and 30
  • \* right handedness

Exclusion Criteria

  • \* Diagnosis of a psychiatric disorder (DSM\-V)
  • \* Diagnosis of a neurological disorder
  • \* Very high (\>30\) or low (\>18\) BMI
  • \* Current recreational drug use/dependence (CIDI)
  • \* Current alcohol dependence (CIDI)
  • \* High blood pressure (\>150 systolic, \>100 diastolic)
  • \* Non\-responders to the mild stressor in session 1

Outcomes

Primary Outcomes

Not specified

Similar Trials